PRUNE: A Potential Drug Target Or Biomarker (G158471)

Target Name: PRUNE2

NCBI ID: G158471

PRUNE2

PRUNE: A Potential Drug Target Or Biomarker

PRUNE2, also known as Prune homolog 2 with BCH domain, transcript variant 1, is a gene that has been identified as a potential drug target or biomarker. The gene is located on chromosome 16 and encodes a protein known as Prune.

Prune is a protein that is involved in the regulation of cell growth and differentiation. It is a key regulator of the BCH domain, a protein-coding region that is found in many proteins. The BCH domain is a unique feature that is found in a variety of organisms, including humans. It is involved in the regulation of protein function and interacts with other proteins to control the structure and stability of these proteins.

Prune has been shown to play a role in the regulation of cellular processes that are important for normal development and growth. It is involved in the regulation of cell proliferation, differentiation, and cell survival. It has also been shown to play a role in the regulation of cellular interactions with the surrounding environment, including the regulation of cell adhesion and migration.

In addition to its role in cell regulation, Prune has also been shown to be involved in the development and progression of various diseases. For example, it has been shown to be involved in the development of cancer, and it has also been shown to be involved in the development of neurodegenerative diseases.

Given the significance of Prune's role in cell regulation and its involvement in the development of various diseases, it is a promising target for drug development. Researchers are currently working to identify small molecules that can modulate Prune's activity and develop these drugs for use in treating various diseases.

In addition to its potential as a drug target, Prune also has the potential as a biomarker. Its involvement in the regulation of cell growth and differentiation makes it an attractive candidate for use as a biomarker for tracking disease progression. This is because the activity of Prune can be easily measured and its levels can be detected in biological samples such as blood or tissue.

In conclusion, Prune is a gene that has the potential to be a drug target or biomarker. Its involvement in the regulation of cell growth and differentiation makes it an attractive candidate for both drug development and biomarker research. Further research is needed to fully understand the role of Prune in cell regulation and its potential as a drug and biomarker.

Protein Name: Prune Homolog 2 With BCH Domain

Functions: May play an important role in regulating differentiation, survival and aggressiveness of the tumor cells

The "PRUNE2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRUNE2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets